牛ヘルスケア市場：製品タイプ、エンドユーザー、地域別、2025年～2033年

牛ヘルスケアの世界市場規模は2024年に91億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに125億米ドルに達し、2025年から2033年にかけて3.44%の成長率（CAGR）を示すと予測しています。動物性タンパク質に対する需要の増大、可処分所得水準の拡大、人畜共通感染症の蔓延が市場を牽引する主な要因のひとつです。

牛ヘルスケアとは、牛の肉体的・精神的健康のあらゆる側面の管理を指します。家畜の幸福と生産性を維持するために、健康問題の予防、診断、治療を行う。牛ヘルスケアの主な目的は、病気の蔓延を防ぎ、最適な栄養と成長を確保し、安全で清潔な環境を提供し、効果的な疾病管理対策を実施することです。牛群の健康状態を定期的にモニタリング・評価することは、潜在的な健康問題を早期に発見し、治療するために不可欠です。効果的な牛ヘルスケアには、適切な管理方法、獣医学的ケア、薬の適切な使用の組み合わせが必要です。これには、ワクチン接種プログラム、寄生虫駆除、栄養管理、疾病サーベイランスプログラムなどが含まれます。さらに、適切な牛ヘルスケアを実施することで、動物の福祉を向上させ、生産性を高め、畜産業の持続可能性を促進することができます。

牛ヘルスケア市場動向：

市場を牽引する主な要因のひとつは、世界の人口増加による動物性タンパク質需要の増大です。また、大衆の可処分所得水準の拡大により、牛を含む家畜の生産が増加しており、市場の見通しは明るいです。このほか、牛結核、ブルセラ症、サルモネラ症などの人獣共通感染症の流行が増加しているため、動物の健康と疾病対策が重視されています。これに加えて、家畜生産者の間で、事業の持続可能性を確保するために動物の健康と福祉が重要であるという意識が高まっていることも、市場の成長にプラスの影響を与えています。これに伴い、特に新興経済圏における酪農産業の急激な成長が市場成長を後押ししています。これらの要因とは別に、家畜生産への投資の増加が、この産業を支える牛ヘルスケア製品とサービスの需要増につながっています。さらに、環境問題への関心の高まりから、持続可能な畜産を促進する牛用ヘルスケア製品やサービスへの注目が高まっています。さらに、世界各国の政府は、動物用医薬品の安全で倫理的な使用を保証するために、疾病監視プログラム、ワクチン接種キャンペーン、規制など、動物の健康と福祉を促進するためのイニシアチブを取っています。さらに、技術の著しい進歩により、ワクチン、検査、医薬品など、新しく革新的な牛ヘルスケア製品やサービスの開発が進んでおり、市場の見通しは明るいです。

本レポートで扱う主な質問

• 世界の牛ヘルスケア市場の市場規模は？
• 2025-2033年における世界の牛ヘルスケア市場の予想成長率は？
• 世界の牛ヘルスケア市場を牽引する主要因は何か？
• 世界の牛ヘルスケア市場に対するCOVID-19の影響は？
• 世界の牛ヘルスケア市場のエンドユーザー別内訳は？
• 世界の牛ヘルスケア市場における主要地域は？
• 世界の牛ヘルスケア市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界の牛ヘルスケア市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：製品タイプ別

• ワクチン
  • 市場動向
  • 市場予測
• 医薬品
  • 市場動向
  • 主要セグメント
    • 鎮痛剤
    • 抗感染
    • 抗炎症
    • 寄生虫駆除剤
    • その他
  • 市場予測
• 飼料添加物
  • 市場動向
  • 主要セグメント
    • 薬用
    • 栄養
  • 市場予測

第7章 市場内訳：エンドユーザー別

• 酪農場
  • 市場動向
  • 市場予測
• 動物病院
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第8章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第9章 促進要因・抑制要因・機会

• 概要
• 促進要因
• 抑制要因
• 機会

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第12章 価格分析

第13章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • BioZyme Inc.
  • Boehringer Ingelheim International GmbH（C.H. Boehringer Sohn AG & Co. KG）
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated
  • Merck & Co. Inc.
  • Virbac
  • Zoetis Inc.

List of Figures

• Figure 1: Global: Cattle Healthcare Market: Major Drivers and Challenges
• Figure 2: Global: Cattle Healthcare Market: Sales Value (in Billion USD), 2019-2024
• Figure 3: Global: Cattle Healthcare Market Forecast: Sales Value (in Billion USD), 2025-2033
• Figure 4: Global: Cattle Healthcare Market: Breakup by Product Type (in %), 2024
• Figure 5: Global: Cattle Healthcare Market: Breakup by End User (in %), 2024
• Figure 6: Global: Cattle Healthcare Market: Breakup by Region (in %), 2024
• Figure 7: Global: Cattle Healthcare (Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 8: Global: Cattle Healthcare (Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 9: Global: Cattle Healthcare (Pharmaceuticals) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 10: Global: Cattle Healthcare (Pharmaceuticals) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 11: Global: Cattle Healthcare (Feed Additives) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 12: Global: Cattle Healthcare (Feed Additives) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 13: Global: Cattle Healthcare (Dairy Farms) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 14: Global: Cattle Healthcare (Dairy Farms) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 15: Global: Cattle Healthcare (Veterinary Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 16: Global: Cattle Healthcare (Veterinary Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 17: Global: Cattle Healthcare (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 18: Global: Cattle Healthcare (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 19: North America: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: North America: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: United States: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 22: United States: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 23: Canada: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 24: Canada: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 25: Asia-Pacific: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 26: Asia-Pacific: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 27: China: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 28: China: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 29: Japan: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 30: Japan: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 31: India: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 32: India: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 33: South Korea: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 34: South Korea: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 35: Australia: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 36: Australia: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 37: Indonesia: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 38: Indonesia: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 39: Others: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: Others: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 41: Europe: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 42: Europe: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 43: Germany: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 44: Germany: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 45: France: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 46: France: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 47: United Kingdom: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 48: United Kingdom: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 49: Italy: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 50: Italy: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 51: Spain: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 52: Spain: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 53: Russia: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 54: Russia: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 55: Others: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 56: Others: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 57: Latin America: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 58: Latin America: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 59: Brazil: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 60: Brazil: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 61: Mexico: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 62: Mexico: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 63: Others: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 64: Others: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 65: Middle East and Africa: Cattle Healthcare Market: Sales Value (in Million USD), 2019 & 2024
• Figure 66: Middle East and Africa: Cattle Healthcare Market: Breakup by Country (in %), 2024
• Figure 67: Middle East and Africa: Cattle Healthcare Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 68: Global: Cattle Healthcare Industry: Drivers, Restraints, and Opportunities
• Figure 69: Global: Cattle Healthcare Industry: Value Chain Analysis
• Figure 70: Global: Cattle Healthcare Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Cattle Healthcare Market: Key Industry Highlights, 2024 & 2033
• Table 2: Global: Cattle Healthcare Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
• Table 3: Global: Cattle Healthcare Market Forecast: Breakup by End User (in Million USD), 2025-2033
• Table 4: Global: Cattle Healthcare Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 5: Global: Cattle Healthcare Market: Competitive Structure
• Table 6: Global: Cattle Healthcare Market: Key Players

The global cattle healthcare market size reached USD 9.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.5 Billion by 2033, exhibiting a growth rate (CAGR) of 3.44% during 2025-2033. The augmenting demand for animal protein, expanding disposable income levels, and increasing prevalence of zoonotic diseases represent some of the key factors driving the market.

Cattle healthcare refers to the management of all aspects of the physical and mental health of cattle. It involves preventing, diagnosing, and treating health issues in order to maintain the well-being and productivity of the animals. The primary objectives of cattle healthcare include preventing the spread of diseases, ensuring optimal nutrition and growth, providing a safe and clean environment, and implementing effective disease control measures. Regular monitoring and evaluation of the herd's health are essential for the early detection and treatment of potential health issues. Effective cattle healthcare requires a combination of good management practices, veterinary care, and appropriate use of medications. This may include vaccination programs, parasite control, nutritional management, and disease surveillance programs. Moreover, implementing proper cattle healthcare practices can improve animal welfare, enhance productivity, and promote sustainability in the livestock industry.

Cattle Healthcare Market Trends:

One of the primary factors driving the market is the augmenting demand for animal protein due to the growing population globally. Additionally, on account of the expanding disposable income levels of the masses, there is a rise in the production of livestock, including cattle, thus creating a positive market outlook. Other than this, the increasing prevalence of zoonotic diseases, such as bovine tuberculosis, brucellosis, and salmonellosis, is creating a greater emphasis on animal health and disease control measures. Besides this, the rising awareness among livestock producers regarding the importance of animal health and welfare to ensure the sustainability of their operations is positively influencing market growth. In line with this, the exponential growth in the dairy industry, specifically in emerging economies, is propelling the market growth. Apart from these factors, the increasing investment in livestock production is leading to increased demand for cattle healthcare products and services to support the industry. Furthermore, the growing environmental concerns have led to an increasing focus on cattle healthcare products and services that promote sustainable livestock production. Moreover, governments across the world are taking initiatives to promote animal health and welfare, such as disease surveillance programs, vaccination campaigns, and regulations, to ensure the safe and ethical use of veterinary drugs. Furthermore, significant technological advancements are leading to the development of new and innovative cattle healthcare products and services, such as vaccines, tests, and medicines, thus creating a positive market outlook.

Key Market Segmentation:

Product Type Insights:

• Vaccines
• Pharmaceuticals
• Analgesics
• Anti-infective
• Anti-inflammatory
• Parasiticides
• Others
• Feed additives
• Medicinal
• Nutritional

End User Insights:

• Dairy farms
• Veterinary hospitals
• Others

Regional Insights:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cattle healthcare. Some of the factors driving the North America cattle healthcare market included increasing demand for animal protein, technological advancements in veterinary medicine, and rising awareness of animal welfare.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global cattle healthcare market. Detailed profiles of all major companies have also been provided. Some of the companies covered include BioZyme Inc., Boehringer Ingelheim International GmbH (C.H. Boehringer Sohn AG & Co. KG), Ceva Sante Animate, Elanco Animal Health Incorporated, Merck & Co. Inc., Virbac, Zoetis Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

• 1. How big is the global cattle healthcare market?
• 2. What is the expected growth rate of the global cattle healthcare market during 2025-2033?
• 3. What are the key factors driving the global cattle healthcare market?
• 4. What has been the impact of COVID-19 on the global cattle healthcare market?
• 5. What is the breakup of the global cattle healthcare market based on the end user?
• 6. What are the key regions in the global cattle healthcare market?
• 7. Who are the key players/companies in the global cattle healthcare market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Cattle Healthcare Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Vaccines
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Pharmaceuticals
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Analgesics
    • 6.2.2.2 Anti-Infective
    • 6.2.2.3 Anti-Inflammatory
    • 6.2.2.4 Parasiticides
    • 6.2.2.5 Others
  • 6.2.3 Market Forecast
• 6.3 Feed Additives
  • 6.3.1 Market Trends
  • 6.3.2 Key Segments
    • 6.2.2.1 Medicinal
    • 6.2.2.2 Nutritional
  • 6.3.3 Market Forecast

7 Market Breakup by End User

• 7.1 Dairy Farms
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Veterinary Hospitals
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

• 9.1 Overview
• 9.2 Drivers
• 9.3 Restraints
• 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 BioZyme Inc.
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
  • 13.3.2 Boehringer Ingelheim International GmbH (C.H. Boehringer Sohn AG & Co. KG)
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
  • 13.3.3 Ceva Sante Animale
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
  • 13.3.4 Elanco Animal Health Incorporated
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
  • 13.3.5 Merck & Co. Inc.
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
    • 13.3.5.4 SWOT Analysis
  • 13.3.6 Virbac
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
    • 13.3.6.4 SWOT Analysis
  • 13.3.7 Zoetis Inc.
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 Financials
    • 13.3.7.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.